Interaction between nitric oxide and subsets of human T lymphocytes with differences in glutathione metabolism

Immunology

Volumn 107, Issue 3, 2002, Pages 334-339

  Roozendaal, Ramon ^a   Kauffman, Henk F ^a   Dijkhuis, Anne Jan ^a   Ommen, Elisabeth T V ^a   Postma, Dirkje S ^a   De Monchy, Jan G R ^a   Vellenga, Edo ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACIVICIN; CD28 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD69 ANTIGEN; CYSTEINE; GAMMA GLUTAMYLTRANSFERASE; GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE SURFACE MARKER; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MONOCLONAL ANTIBODY CD3; MULTIDRUG RESISTANCE PROTEIN 1; NITRIC OXIDE; SPERMINE; SPERMINE NONOATE; UNCLASSIFIED DRUG;

ADDITION REACTION; APOPTOSIS; ARTICLE; DRUG SENSITIVITY; GLUTATHIONE METABOLISM; HELPER CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

EID: 0036434375     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01502.x     Document Type: Article

References (23)

1. Asensi M, Sastre J, Pallardo FV, Lloret A, Lehner M, Garcia-de-la Asuncion J, Vina J. Ratio of reduced to oxidized glutathione as indicator of oxidative stress status and DNA damage. Methods Enzymol 1999; 299:267-76.
2. Kirlin WG, Cai J, Thompson SA, Diaz D, Kavanagh TJ, Jones DP. Glutathione redox potential in response to differentiation and enzyme inducers. Free Radic Biol Med 1999; 27:1208-18.
3. Marchetti P, Decaudin D, Macho A, Zamzami N, Hirsch T, Susin SA, Kroemer G. Redox regulation of apoptosis: Impact of thiol oxidation status on mitochondrial function. Eur J Immunol 1997; 27:289-96.
4. Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, Kappler J, Marrack PC. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 1999; 10:735-44.
5. Chlichlia K, Peter ME, Rocha M, Scaffidi C, Bucur M, Krammer PH, Schirrmacher V, Umansky V. Caspase activation is required for nitric oxide-mediated, CD95 (APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells. Blood 1998; 91:4311-20.
6. Ushmorov A, Ratter F, Lehmann V, Droge W, Schirrmacher V, Umansky V. Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release. Blood 1999; 93:2342-52.
7. Hendrich S, Pitot HC. Enzymes of glutathione metabolism as biochemical markers during hepatocarcinogenesis. Cancer Metastasis Rev 1987; 6:155-78.
8. Hanigan MH, Pitot HC. Gamma-glutamyl transpeptidase - Its role in hepatocarcinogenesis. Carcinogenesis 1985; 6:165-72.
9. Karp DR, Carlisle ML, Mobley AB, Nichols TC, Oppenheimer-Marks N, Brezinschek RI, Holers VM. Gamma-glutamyl transpeptidase is up-regulated on memory T lymphocytes. Int Immunol 1999; 11:1791-800.
10. Hogg N, Singh RJ, Konorev E, Joseph J, Kalyanaraman B. S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. Biochem J 1997; 323:477-81.
11. Keppler D, Leier I, Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 1997; 378:787-91.
12. Roozendaal R, Vellenga E, De Jong MA, Traanberg KF, Postma DS, De Monchy JGR, Kauffman HF. Gamma-glutamyltranspeptidase mediates resistance of activated human Th2 cell to nitric oxide mediated apoptosis. Int Immunol 2002; 13:519-28.
13. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995; 184:39-51.
14. + peripheral blood cells. Clin Cancer Res 1998; 4:1727-36.
15. - donation by S-nitrosothiols: Implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 1995; 318:279-85.
16. Hogg N, Singh RJ, Kalyanaraman B. The role of glutathione in the transport and catabolism of nitric oxide. FEBS Lett 1996; 382:223-8.
17. -) using L-cysteine. Biochem Biophys Res Commun 1994; 201:54-62.
18. Umansky V, Rocha M, Breitkreutz R, Hehner S, Bucur M, Erbe N, Droge W, Ushmorov A. Glutathione is a factor of resistance of Jurkat leukemia cells to nitric oxide-mediated apoptosis. J Cell Biochem 2000; 78:578-87.
19. Bauer JA, Booth BP, Fung H-L. Nitric oxide donors. Biochemical pharmacology and therapeutics. Adv Pharmacol 1995; 34:361-81.
20. Kashiba M, Kasahara E, Chien KC, Inoue M. Fates and vascular action of S-nitrosoglutathione and related compounds in the circulation. Arch Biochem Biophys 1999; 363:213-8.
21. Henson SE, Nichols TC, Holers VM, Karp DR. The ectoenzyme γ-glutamyltranspeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes. J Immunol 1999; 163:1845-52.
22. Roozendaal R, Vellenga E, Postma DS, De Monchy JG, Kauffman HF. Nitric oxide selectively decreases interferon-gamma expression by activated human T lymphocytes via a cGMP-independent mechanism. Immunology 1999; 98:393-9.
23. Robbiani DF, Finch RA, Jager D, Muller WA, Sartorelli AC, Randolph GJ. The leukotriene C (4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 2000; 103:757-68.